Edward J. Fiorentino and the Value of a Third Invitation

In February 2016, Edward J. Fiorentino agreed to start another company with people who had already helped him build and sell two. The new business was TerSera Therapeutics. The partner was GTCR. The interesting word in the announcement was “third.” A first partnership begins with a proposition. By the third, everyone has had ample opportunity to discover whether they enjoy working together when the proposition becomes a payroll.

There was very little interval between chapters. Crealta Pharmaceuticals, where Fiorentino had been chairman and chief executive, was acquired by Horizon Pharma in January 2016. TerSera’s formation was announced the following month. The sequence puts a useful wrinkle in the familiar entrepreneurial biography. Here was an executive whose next beginning grew directly out of an established working relationship. The cast had experience together; the company still had to be built.

Fiorentino had already led Actient Pharmaceuticals before Crealta. Each business had been assembled through acquisitions and operating work, then sold. TerSera would extend the partnership rather than merely commemorate it. There is a particular kind of professional endorsement in being asked back to do the difficult part again. A congratulatory dinner lasts an evening. Another company is a rather longer engagement.

Today he serves as TerSera’s executive chairman, having led the company as chairman and CEO from its inception through December 2023. His career now contains both the act of starting businesses and the act of changing his place within one. Between those two sits the less photogenic business of keeping an organization moving after the announcement has been filed away.

Before the first company, twenty-two years

Fiorentino began his career at Bristol-Myers and spent 22 years at Abbott before the Actient venture. His responsibilities there included U.S. sales, marketing, and new product planning as corporate vice president of commercial operations. He also held a division presidency and served as executive vice president of TAP Pharmaceuticals, Abbott’s joint venture with Takeda. The positions brought him into different forms of corporate management before he became a company builder in partnership with private capital.

Consider the practical distance between those assignments. Sales and marketing require coordination across the people who represent a business. Product planning asks what an organization should prepare to do next. A joint venture adds a second corporate parent to the conversation. These are different organizational problems, even when they share an industry. His progression supplied experience in several of them before the first GTCR company had a name.

His education was in business: a bachelor of science in business administration from the State University of New York and an MBA from Syracuse University. That detail belongs near the front of his story. The work that later distinguished his career concerned how businesses were formed, operated, financed, and transferred. A portfolio could be acquired in a transaction; turning its parts into a functioning company required management.

The long Abbott chapter also changes the chronology of the entrepreneurial years. Actient did not begin at the start of his working life. It followed more than two decades inside a large organization. The new-company phase therefore carried an extensive corporate apprenticeship into a smaller setting, where the executive team and its financial partner would be choosing what to buy and what to build around it.

Actient, then Crealta: the short interval

GTCR and Fiorentino formed Actient in March 2009. Over its life with the firm, the business completed five acquisitions. Auxilium acquired Actient in April 2013 in a transaction with $585 million of base consideration, subject to debt, cash, working-capital, and expense adjustments. The distinction matters: the transaction figure describes the business sale. It is no individual’s personal payday.

The five acquisitions give the Actient chapter a shape. This was a company assembled over time, with successive transactions adding to what management had to run. Signing a purchase agreement is a milestone, but it also enlarges the list of things that need to work together the following morning. The eventual sale gave that first partnership an endpoint. It also supplied a shared history for whatever came next.

By August 2013, Fiorentino and GTCR were announcing Crealta. The firm said it could invest up to $200 million of equity to support the strategy. That was a stated investment capacity, rather than a claim that the entire amount had already been spent. Fiorentino became chairman and CEO. Four months after the first company’s sale, the relationship had moved from a completed transaction to a fresh commitment.

Crealta made its first product acquisition in December 2013 and acquired substantially all of Savient Pharmaceuticals’ assets in January 2014 following a bankruptcy auction. These were different kinds of transactions within the same young business. One began with a product purchase; the other passed through an auction process. The company’s early calendar was already a calendar of execution.

Crealta ultimately grew through four transactions and was acquired by Horizon in January 2016. Across Actient and Crealta, the pattern had become recognizable: establish a management partnership, acquire assets, operate the resulting business, and find a buyer. The companies had different names and separate histories. The continuing relationship belonged to Fiorentino, his colleagues, and the investment firm that backed them.

A partnership gets a longer calendar

TerSera’s February 2016 announcement arrived with that history behind it. Dean Mihas, then a GTCR managing director, credited the team’s strategic vision and operating ability. Fiorentino’s own emphasis was on the working relationship. “GTCR was an ideal partner to Crealta and Actient,” he said. It is a compact statement, but it locates his enthusiasm in experience rather than in a newly exchanged business card.

Ben Daverman was another GTCR executive involved in the formation announcement. The names are useful because a repeated partnership consists of actual people as well as capital. Corporate biographies tend to compress an investor into four letters. The decisions behind those letters still require agreement about opportunities, resources, and the work an executive team will take on.

TerSera’s first platform acquisition followed in March 2017. Its formation and its first platform purchase were separate events, more than a year apart. That interval is easily lost in a compressed timeline. A company can exist before its central acquisition has closed; the early work includes finding the transaction around which the operating business will take shape.

In April 2023, GTCR established an Evergreen continuation fund to acquire TerSera from its earlier Fund XI. The arrangement provided additional time and capital commitments for the business while offering the earlier fund’s investors a route to liquidity. It gave TerSera a different financial calendar from a straightforward sale to another operating company.

For Fiorentino’s story, the consequence is concrete. The third venture continued under the GTCR relationship beyond the ownership period of the original fund. Actient and Crealta had each ended their GTCR chapters with sales to other companies. TerSera’s next stage instead involved a new investment vehicle supporting the existing business. Repetition had produced a different sort of continuation.

“GTCR was an ideal partner to Crealta and Actient.”

Edward J. Fiorentino · February 2016

The chair changes; the connection stays

In January 2024, Fiorentino became executive chairman. Edward Donovan serves as CEO. The titles mark a division of responsibility at a business Fiorentino had helped establish eight years earlier. Founding and running a company are often written as one continuous action. A leadership transition puts a visible joint between them.

His board work stretches beyond TerSera. He joined the board of Senseonics Incorporated in March 2012 and was elected to the Senseonics Holdings board in December 2015. Its 2026 proxy materials continue to identify him as a director. Those dates overlap with the Crealta and TerSera years, adding an ongoing governance role alongside the businesses he led.

The chairmanship offers a different point from which to read the whole sequence. Earlier chapters concerned forming a company and taking responsibility for its operations. The present chapter includes remaining involved while another executive holds the CEO title. The organizational chart makes that change plain, without requiring a grand farewell scene or a claim that the founder has stopped working.

A website for the class of ’76

Then there is Aquinas. Fiorentino belongs to the school’s class of 1976 and serves on its board of trustees. In summer 2024, Aquinas thanked him for helping fund its new website. Beside the business transactions, it is a pleasantly specific detail: an alumnus supporting the way his old school introduces itself to its next families.

A website is a practical gift. It needs photographs, clear information, and enough attention to make a visitor’s first encounter useful. For a school, it also gives students, parents, and alumni a place to describe their experience. Fiorentino’s contribution supported that public-facing work at an institution connected to his own early education.

The school described a donor who preferred discretion. The acknowledgment is revealing in its modest scale: a named project, a contribution that helped make it happen, and a continuing trustee relationship. His corporate career contains repeated commitments to people he had worked with before. Aquinas supplies another enduring connection, this time measured from a graduating class.

Place the school project beside the third company and the portrait becomes less remote. There are transactions, executive titles, and years of board service. There is also an old school with a new website. Fiorentino’s career can be followed through the organizations he helped create, the responsibilities he later changed, and the earlier institution to which he kept returning. The next invitation, it seems, need not always come from an investor.